Alnylam Pharmaceuticals
ALNY
#640
Rank
NZ$54.52 B
Marketcap
$422.71
Share price
-3.51%
Change (1 day)
40.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company